Lexpert

Building a legal function at a high-growth company means learning that templates from previous jobs only get you so far. “The process of building Jobber’s legal function required getting to know the business and designing a unique and customized roadmap based on how we do business here,” says Melissa Reiter, general counsel and senior director at Jobber, the Edmonton-based field service management platform.

Fasken on how shadow AI and fiduciary duty are colliding for Canadian directors Fasken's corporate governance partners examine how AI is reshaping directors' legal duties, drawing on a May 2026 Nasdaq survey, a March 2026 Australian Federal Court ruling, and an active Delaware M&A dispute. A key distinction they highlight is the gap between approved AI and so-called “shadow AI,” i.e., unsanctioned tools that roughly two-thirds of board members are reportedly already using.

Canadian venture financing hit a five-year high in 2025, even amid interest rate cuts and a sharp shift in US trade policy. Investors kept committing capital, and the year’s deal data reflects that. Osler, Hoskin & Harcourt LLP’s Deal Points Report provides unique analysis of that data. It doesn’t rely solely on public filings but draws on anonymized information from the firm’s own transactions, including British Columbia financings that rarely surface in other datasets.

Private equity firm Onex Partners is buying AirSprint Inc., the Calgary-based company that pioneered fractional jet ownership in Canada, in a deal that hands the country's largest private aviation operator its first institutional backers. The acquisition, made through the Onex Partners Opportunities Fund alongside TriWest Capital Partners and other co-investors, will keep AirSprint's leadership in place.

Regulations target consumer-targeted fraud in line with development of National Anti-Fraud Strategy The federal government has pre-published proposed regulations addressing consumer-targeted fraud for a 30-day feedback period. According to the government, this marks the initial step in efforts to develop a National Anti-Fraud Strategy.

On May 8, 2026, Certara, Inc., a global leader in model-informed drug development, completed the sale of its regulatory and medical writing business to Veristat for total consideration of up to US$135 million. The purchase price comprises US$100 million in cash at closing, subject to customary working capital and other adjustments, plus up to US$35 million in contingent earn-out tied to the future performance of the business, with up to US$15 million of the closing payment subject to escrow.

On April 15, 2026, GSK plc (GSK) completed its acquisition of 35Pharma Inc., a Montréal-based, private, clinical-stage biopharmaceutical company specializing in the development of novel protein-based therapeutics, for US$950 million in cash. The transaction, first announced on February 25, 2026, gives GSK full ownership of 35Pharma and its pipeline, headlined by HS235, a potential best-in-class investigational medicine for the treatment of pulmonary hypertension (PH).

On February 27, 2026, the Government of Ontario announced a provincial guarantee through the Indigenous Opportunities Financing Program (IOFP), administered by the Building Ontario Fund, to support a $250 million investment by the Saugeen Ojibway Nation (SON) to increase production of life-saving medical isotopes as part of its expanded partnership with Bruce Power. The provincial guarantee is the largest of its kind since the Indigenous loan guarantee program began in 2009.

On March 18, 2026, GE HealthCare (“GE HealthCare”), the Chicago-based health technology company, completed its acquisition of Intelerad, a leading medical imaging software provider for the healthcare industry, for a base purchase price of US$2.3 billion in cash, subject to customary adjustments. The transaction, which had been announced on November 20, 2025, was funded with cash on hand and proceeds from debt financing.

On March 16, 2026, Canopy Growth Corporation (“Canopy Growth”), the Smiths Falls, Ontario-based cannabis company, completed its acquisition of MTL Cannabis Corp. (“MTL Cannabis”) by way of a plan of arrangement, creating Canada's leading medical cannabis business by revenue.